Catatonia Atlas Atlas home

World information meter

Catatonia worldwide.

Explore how many catatonia episodes might begin each day, and what clinical studies have measured about treatment and recovery.

Modeled episode starts per day

986

WorldwideFull-day average

904–1,073 using the study rate’s lower and upper confidence limits.

Select a region
4.34 episodes per 100,000 person-yearsHow it’s calculated

The meter applies a local study rate to a population. An episode can recur in the same person. A worldwide count of people symptomatic today is unavailable.

Population model

The regional picture

The same study rate is applied to every region. The size of each population drives the differences shown here.

Population on 1 July 2026, all ages. B = billion, M = million. Regional estimates are rounded separately. UN population data

Clinical evidence

Treatment & recovery

Each percentage belongs to the study population and time period on its card. Open a source to see how researchers defined the outcome.

Treatment use

Received a benzodiazepine

88.3%

181 of 205 patients

US tertiary-care hospital, adults with catatonia · Selected hospital episodes, 2001–2021

What this measures

181 patients received a benzodiazepine during the episode reviewed. Some also received other treatments.

Original study

Treatment use

Received electroconvulsive therapy (ECT)

9.1%

5,645 of 61,990 hospitalizations

US acute-care discharges with a catatonia diagnosis, all ages · 2016–2020

What this measures

Nationally weighted discharge estimates. The measure counts recorded procedures during a stay. It cannot measure access after discharge.

Original study

Acute outcomes

Catatonic signs resolved with lorazepam

70%

21 of 30 inpatients

Puducherry, India, prospective open trial · During a five-day trial

What this measures

Clinicians measured disappearance of catatonic signs. The study observed 30 treated inpatients and did not establish lasting recovery of everyday function.

Original study

Acute outcomes

Clinical response after ECT

80.8%

21 of 26 patients

Pisa, Italy, bipolar disorder with benzodiazepine-resistant catatonia · End of the ECT course

What this measures

Clinicians rated 21 patients as responders. The group was selected for ECT after previous treatment, making direct comparison with the separate lorazepam study inappropriate.

Original study

Follow-up

Catatonia returned during follow-up

48.8%

148 of 303 patients

Bengaluru, India, people with a psychotic or mood disorder · Median follow-up 29.8 months

What this measures

A return of catatonic symptoms was recorded in 148 people. The follow-up varied by person and the available records cannot establish lifelong recovery.

Original study

Clinical context

Schizophrenia in a catatonia-positive group

47.7%

21 of 44 screen-positive patients

One acute mental health unit in South Africa, ages 16 and older · Sept 2020–Aug 2021

What this measures

Of 44 patients who screened positive for catatonia, 21 had schizophrenia. This answers a different question from how often people with schizophrenia develop catatonia.

Original study

Clinical context

Bipolar disorder in the same group

27.3%

12 of 44 screen-positive patients

One acute mental health unit in South Africa, ages 16 and older · Sept 2020–Aug 2021

What this measures

Bipolar disorder was present in 12 of the same 44 patients with a positive catatonia screen. These hospital findings reflect the local patient mix.

Original study

Clinical context

Autism recorded with pediatric catatonia

15.8%

515 of 3,255 pediatric hospitalizations

US acute-care catatonia discharges, age 18 or younger · 2016–2020

What this measures

A co-occurring autism diagnostic code was recorded in this share of hospital stays. This cannot tell us an autistic child's individual likelihood of catatonia.

Original study

Clinical context

Other encephalitis recorded

6.6%

215 of 3,255 pediatric hospitalizations

US acute-care catatonia discharges, age 18 or younger · 2016–2020

What this measures

This figure covers a specific encephalitis discharge code. Individual hospitalizations may appear in multiple condition groups.

Original study

Clinical context

Catatonia across clinical samples

9%

110,764 clinical participants across 80 samples

74 studies of clinical populations in several countries · Data from 1935–2017

What this measures

The pooled estimate ranged from 6.9% to 11.7% (95% CI), with high variation between studies. Applying this percentage to the general population would give a misleading result.

Original study

Interpreting the evidence

Who was counted?

A new episode, a person receiving care over a year, and a person symptomatic today answer different questions.

South London · one-year prevalence

4.39
people per 100,000 residents per year

2007–2016 average. A resident with a documented episode counted once in each calendar year affected (95% CI 4.03–4.77).

Read the study

United States · one-year hospitalizations

5.15
catatonia-related hospitalizations per 100,000 residents

2020 extrapolation from hospital data (95% CI 5.08–5.23). One person can contribute more than one hospital stay.

Read the study

United States · one-day inpatient illustration

6,986
modeled psychiatric inpatients on one day in 2020

The authors applied a pooled 9% clinical rate to a one-day census of 77,622 psychiatric inpatients. They did not examine those patients for catatonia.

Read the study

Publication watch

Published case reports

These records track publication activity. A report can describe several people, and its publication date can be much later than the episode.

Browse catatonia case reports in Europe PMC.

Sources & methods

Behind the meter

Clinical evidence and population data reviewed 22 November 2026 (UTC).

The calculation

Population × annual study rate
÷ 100,000 ÷ 365.25

The result is an average number of episode starts per day. “Today so far” multiplies that average by the fraction of the UTC day elapsed. It assumes a steady pace.

Study confidence limits span uncertainty in the original rate. Local differences in access to care, timing, diagnosis and recording add uncertainty the meter cannot quantify.

Study assumptions

South London · DSM-5 criteria

Residents with a documented episode meeting DSM-5 criteria. Researchers identified 539 onsets in 373 people across 12.42 million person-years. The rate in 2007–2016 was 4.34 episodes per 100,000 person-years (95% CI 3.98–4.72). Study methods

South London · broader clinical definition

The original analysis counted episodes with a clinician diagnosis and at least two Bush–Francis screening signs. It draws on the same records as the stricter scenario. The rate in 2007–2016 was 10.6 episodes per 100,000 person-years (95% CI 10–11.1). Study methods

Population and geographic boundaries

UN World Population Prospects 2024 · medium projection. The six regions together cover the 8,300,678,396 people in its 1 July 2026 projection. Download population data

Map outlines use Natural Earth land geography. The dots draw the land surface. Each colored button selects a region.

Original sources

  1. United Nations · World Population Prospects 2024Population Division projections for both sexes and all ages, medium variant. The regional comparison uses the population on 1 July 2026.
  2. UN data download · Demographic indicators, medium variantDownload the original compressed CSV. Select the World and the six geographic regions, year 2026, column TPopulation1July. Multiply thousands by 1,000 to get people.
  3. Luccarelli et al. · Population-based incidence and prevalence of catatonia (2025)The investigators reanalyzed South London clinical records and US hospital data. They measured episode onsets, annual prevalence and hospitalizations. Regional access to care and diagnostic practice affect these rates.
  4. Luccarelli et al. · Case definitions and annual countsSupplemental tables define the South London numerator. Each episode onset counted separately for incidence. A resident could count only once within a given year for prevalence.
  5. Rogers et al. · Catatonia in South London clinical recordsThe original catchment study covered residents of all ages during 2007–2016. Its broader definition yielded 1,316 recorded episodes in 852 people.
  6. Luccarelli et al. · US pediatric and adult hospitalizations (2024)A nationally weighted discharge sample produced an estimated 61,990 US acute-care hospitalizations with a catatonia diagnosis during 2016–2020. Each hospitalization is a separate record.
  7. Catatonia treatments and risk of recurrence (2026)Records of 205 adults at a US tertiary hospital, 2001–2021. Treatment exposure came from one selected episode per patient, defined differently for those with and without documented recurrence.
  8. Payee et al. · Short-term response to lorazepam (1999)An open prospective study in Puducherry, India, assessed catatonic signs in 30 inpatients during a five-day lorazepam trial.
  9. Medda et al. · ECT for catatonia with bipolar disorderAn Italian study followed 26 people with bipolar disorder and catatonia that had persisted after benzodiazepines. The outcome was clinical response by the end of the ECT course.
  10. Risk factors for catatonia relapse in psychotic and affective disorders (2025)A retrospective Indian specialty-center cohort tracked 303 people with catatonia and an associated mood or psychotic disorder. Median follow-up was 29.8 months.
  11. Zingela et al. · Screening in a South African acute mental health unit (2022)A Nelson Mandela Bay unit screened 241 new admissions aged 16 or older. The Bush–Francis screen identified 44 people and the DSM-5 criteria identified 16.
  12. Braga et al. · Catatonia and Wilson disease in Brazil (2019)Clinicians in Recife described a patient evaluated for catatonia who had Wilson disease. The case illustrates a medical association.
  13. Chung and Varghese · Pediatric catatonia in Australia (2008)A Brisbane team described assessment and ECT in one child with severe catatonic symptoms. A case can illustrate a care pathway but cannot establish a treatment rate.
  14. Solmi et al. · Catatonia prevalence in clinical samples (2018)A meta-analysis of 80 clinical samples estimated a pooled prevalence of 9.0% (95% CI 6.9–11.7%). Results varied widely with setting, case mix and sample size.
  15. Zhang et al. · Five-year functional outcomes in Beijing (2026)Global Assessment of Functioning scores were lower at five years in the group with catatonia than in the psychiatric comparison group. Follow-up was available for 31 of 51 and 34 of 56 participants, respectively. The study did not report a population-wide percentage returning to their previous function.
  16. Malignant catatonia · Return to work after hospital dischargeDuring more than a year of follow-up, one patient had no measurable catatonic signs at clinic visits and returned to work. She was still rebuilding her earlier level of everyday function. Her case illustrates why symptom remission and functional recovery need separate measures.